: Mutational heterogeneity in cancer and the search for new cance

: Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013,499(7457):214–218.PubMedCrossRef 29. Reddy EP,

Korapati A, Chaturvedi P, Rane S: IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 2000,19(21):2532–2547.PubMedCrossRef 30. Ernst M, Jenkins BJ: Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet 2004,20(1):23–32.PubMedCrossRef BMS-777607 solubility dmso 31. Fiszer-Kierzkowska A, Vydra N, Wysocka-Wycisk A, Kronekova Z, Jarzab M, Lisowska KM, Krawczyk Z: Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells. BMC Mol Biol 2011, 12:27.PubMedCentralPubMedCrossRef 32. Song L, Turkson J, Karras JG, Jove R, Haura EB: Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 2003,22(27):4150–4165.PubMedCrossRef find more 33. Schust J, Sperl B, Hollis A, Mayer TU, Berg T: Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006,13(11):1235–1242.PubMedCrossRef 34. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009,119(6):1420–1428.PubMedCentralPubMedCrossRef

35. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002,61(5):1714–1728.PubMedCrossRef 36. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: Reverse transcriptase The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000,2(2):76–83.PubMedCrossRef 37. Vernon AE, LaBonne C: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol 2004,14(17):R719-R721.PubMedCrossRef

38. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003,15(6):740–746.PubMedCrossRef 39. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000,407(6801):249–257.PubMedCrossRef 40. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002,29(6 Suppl 16):15–18.PubMed 41. Tonini T, Rossi F, Claudio PP: Molecular basis of angiogenesis and cancer. Oncogene 2003,22(42):6549–6556.PubMedCrossRef 42. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000,407(6801):242–248.PubMedCrossRef 43. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM: Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996,97(12):2792–2802.PubMedCentralPubMedCrossRef 44.

Comments are closed.